Intrinsic Value of S&P & Nasdaq Contact Us

Zynex, Inc. ZYXI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
63/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.38
+11404%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Zynex, Inc. (ZYXI) has a negative trailing P/E of 0.0, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -4,435.87%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — analyst target implies upside (+11404%).
  • Trailing Earnings Yield -4,435.87% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $14.38 (+11404% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 63/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
63/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
54/100
→ Income
~
GROWTH
48/100
→ Income
INCOME
30/100
→ Income

Valuation Snapshot — ZYXI

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio-0.04
P/S Ratio0.02
EV/EBITDA-0.9
Per Share Data
EPS (TTM)$-2.44
Book Value / Share$-1.36
Revenue / Share$3.57
FCF / Share$-0.69
Yields & Fair Value
Earnings Yield-4,435.87%
Dividend Yield0.00%
Analyst Target$14.38 (+11404%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2015 -4.8 0.09 -3.52 1.20 -
2016 134.5 -1.31 -2.50 0.70 -
2017 13.7 0.00 20.27 4.32 -
2018 9.9 0.35 10.07 2.96 -
2019 26.9 0.00 12.93 5.61 0.89%
2020 50.2 -4.52 8.02 5.69 -
2021 22.3 0.32 5.17 2.93 0.00%
2022 31.4 4.29 8.06 3.38 0.68%
2023 39.8 -1.03 8.39 2.10 0.00%
2024 85.5 -1.28 7.16 1.33 0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2015 $-0.08 $11.64M $-2.91M -25%
2016 $0.00 $13.31M $69K 0.5%
2017 $0.20 $23.43M $7.37M 31.4%
2018 $0.26 $31.92M $9.55M 29.9%
2019 $0.25 $45.47M $9.49M 20.9%
2020 $0.24 $80.12M $9.07M 11.3%
2021 $0.40 $130.3M $17.1M 13.1%
2022 $0.44 $158.17M $17.05M 10.8%
2023 $0.27 $184.32M $9.73M 5.3%
2024 $0.09 $192.35M $2.99M 1.6%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.48 $-0.48 – $-0.48 $101.2M $101.2M – $101.2M 1
2027 $-0.39 $-0.39 – $-0.39 $111.1M $111.1M – $111.1M 1
2028 $-0.28 $-0.28 – $-0.28 $121.7M $121.7M – $121.7M 1
2029 $-0.13 $-0.13 – $-0.13 $133.2M $133.2M – $133.2M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message